IgorGolovniov / Shutterstock.com
6 July 2026NewsMedTechMarisa Woutersen

UPC revives patent, but timing sinks Guardant’s appeal

The Unified Patent Court delivers a mixed ruling in a dispute over liquid biopsy technology, overturning a finding that a patent was likely invalid while refusing to grant interim relief because of the patent owner’s delay.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Week Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@lifesciencesipreview.com 


More on this story

MedTech
9 September 2026   The UPC has handed the medical device company a significant win over continuous glucose monitoring tech, granting a broad provisional injunction after finding that SiBio’s rival system was likely to infringe its European patent.
MedTech
3 September 2026   A decision at the USPTO has cleared the way for renewed enforcement in the drugmaker’s dispute over light-based dermatology tech.
MedTech
18 August 2026   The European court has backed Abbott in a dispute over glucose-monitoring technology, while offering guidance on a key added-matter issue.